News Detail
New Delhi, 6 May 2023: The National Pharmaceutical Pricing Authority (NPPA) has fixed the ceiling price of antipsychotic drug risperidone injection (long acting) 25 mg in its latest meeting after deferring the price fixation earlier due to a dispute raised by multinational pharma......
View Details
Source : Pharmabiz
NPPA
antipsychotic drug
risperidone injection
Johnson & Johnson
J&J
DCGI
Restonorm
HFA Formulations
Aleteus Biogenics
schizophrenia
Schedule I
Drugs (Prices Control) Order 2013
Risperdal Consta
CDSCO
DPCO 2013
drugscontrol
Related News
- ‘Sodium Phosphates Enema BP,’ claimed to treat ‘Convulsions’ seized (12-02-2025)
- Substandard Medicines issue raised in Rajya Sabha (12-02-2025)
- Enhancing chemotherapy efficacy; targeting drug resistance with novel molecules: Study (12-02-2025)
- Over 3k brands hit pharma mkt, cancer drug 'Enhertu' tops in sales (12-02-2025)
- FDA slaps China-based API makers with warning letters outlining quality, testing shortfalls (12-02-2025)
- Falsely manufactured RedFer-XT Tablets seized in for violating drug regulations (12-02-2025)
- Health ministry issues final notification on extension of revised Schedule M deadline for MSMEs (12-02-2025)
- Anticancer Drug Pharmacokinetics may differ by Sex (12-02-2025)
- Biovet’s BIOLUMPIVAXIN® vaccine for Lumpy Skin disease receives CDSCO License (12-02-2025)
- Drug Trafficking Network busted on Amritsar-Jamnagar Expressway; Three Individuals, Including a Woman, Arrested (12-02-2025)